M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy - A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Published on Feb 4, 2021in Oral Oncology3.979
· DOI :10.1016/J.ORALONCOLOGY.2021.105189
Anna Viganò (University of Bergamo), Francesca De Felice21
Estimated H-index: 21
(Sapienza University of Rome)
+ 15 AuthorsEster Orlandi23
Estimated H-index: 23
Sources
Abstract
Abstract Purpose Head and neck cancer (HNC) patients are likely to develop severe side effects, which may persist long after the end of treatment and may be responsible for decrease patient’s quality of life. The M.D. Anderson Symptom Inventory- Head and Neck Module (MDASI-HN) is a questionnaire developed to detect patient’s symptom burden. To conduct an Italian language psychometric validation of MDASI-HN among Italian HNC patients on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Working Group. Method and materials To assess construct validity, it was performed a confirmatory factor analysis (CFA) with both a five-factor solution and three-factor solution, which were compared by a chi-square difference test. The concurrent validity was evaluated by the correlation with EORTC QLQ-C30 and HN35, and it was also assessed known-group validity. The internal consistency was tested using Cronbach’s alpha coefficient. Results In total 166 patients (71.7% male) were included in the study, most of patients (56.2%) had an oropharynx cancer and received definitive chemoradiotherapy (51.2%). The chi-square difference test was significant and indicated that the five-factor solution fits the data better than the other one. Regarding CFA, all items had a significant saturation with their respective factors; besides, significant and strong correlations were found among factors. Most of the correlations between MDASI-HN factors and EORTC QLQ-C30 and HN35 were significant. It was found a good internal consistency. Conclusion The MDASI-HN is a valid, short, and easy patient-reported outcome questionnaire which would be useful and efficient in clinical setting.
References23
Newest
#1Cecilie Holländer-Mieritz (UCPH: University of Copenhagen)H-Index: 3
#2Jørgen Johansen (Odense University)H-Index: 39
Last. Helle Pappot (UCPH: University of Copenhagen)H-Index: 21
view all 7 authors...
2 CitationsSource
#1Ester OrlandiH-Index: 23
#2Salvatore AlfieriH-Index: 17
Last. Lisa Licitra (University of Milan)H-Index: 70
view all 5 authors...
Abstract Head and neck cancer (HNC) is a rare disease that can affect different sites and is characterized by variable incidence and 5-year survival rates across Europe. Multiple factors need to be considered when choosing the most appropriate treatment for HNC patients, such as age, comorbidities, social issues, and especially whether to prefer surgery or radiation-based protocols. Given the complexity of this scenario, the creation of a highly specialized multidisciplinary team is recommended ...
15 CitationsSource
#1Katherine Rieke (UNMC: University of Nebraska Medical Center)H-Index: 6
#2Kendra K. Schmid (UNMC: University of Nebraska Medical Center)H-Index: 21
Last. Shinobu Watanabe-Galloway (UNMC: University of Nebraska Medical Center)H-Index: 17
view all 6 authors...
Abstract Objective Though depression often afflicts head and neck cancer (HNC) patients, few studies have examined the association between depression and survival in this particular cancer population. The objective of this study is to investigate the five-year survival of HNC patients by depression status. Materials and methods This study used SEER-Medicare data from 2002–2010 and identified depression diagnosis two years before and one year after cancer diagnosis. HNC patients were identified u...
37 CitationsSource
#1Daniel Sánchez (UdeA: University of Antioquia)H-Index: 2
#2Andrés Chala (University of Caldas)H-Index: 4
Last. Alvaro Sanabria (UdeA: University of Antioquia)H-Index: 25
view all 7 authors...
Abstract Context The assessment of cancer-related symptoms requires culturally adapted and psychometrically validated symptom assessment tools. The M. D. Anderson Symptom Inventory–Head and Neck Module (MDASI-HN) is a useful instrument for measuring symptom burden that was specifically developed for head and neck cancer patients. Objectives To validate the Spanish version of the MDASI-HN. Methods We evaluated the psychometric features of the MDASI-HN in patients with head and neck cancer. We eva...
5 CitationsSource
#1Andrea Greco (University of Milan)H-Index: 15
#2E. OrlandiH-Index: 3
Last. Paolo BossiH-Index: 39
view all 15 authors...
Background Head and neck cancer (HNC) patients can experience symptoms due to the tumor itself or to the treatment, with an impact on health-related quality of life (HRQoL). Patient-reported outcome (PRO) measures pertaining to HRQoL are used in medical research and to support clinical decisions. PRO instrument applicability and cultural adaptation must be tested for each population. The aim of this study is to linguistically validate the Italian translation of the M.D. Anderson Symptom Inventor...
5 CitationsSource
#1Sharon Elad (URMC: University of Rochester Medical Center)H-Index: 43
#2Cyril Meyerowitz (UR: University of Rochester)H-Index: 18
This chapter describes the late adverse events of cancer therapy involving the oral tissues. A summary of the normal anatomy and physiology is followed by a review of the clinical presentation and management of the late oral adverse events in cancer patients. As the oral tissues involved are variable, the nature and quantity of late oral complications are extremely diverse. The impact of these oral complications can result in significantly debilitating basic oral functions, negatively affecting ...
2 CitationsSource
#1Arild André Østhus (University of Bergen)H-Index: 8
#2Anne K. H. Aarstad (Bergen University College)H-Index: 17
Last. Hans Jørgen Aarstad (University of Bergen)H-Index: 23
view all 4 authors...
Summary To examine the survival prediction of head and neck (H&N) Health Related Quality of Life (HRQoL) scores among successfully treated and cognitive functioning H&N squamous cell carcinoma (HNSCC) patients. Through structured interviews, self-reported questionnaires were given to 139 successfully treated HNSCC patients, 67 ± 32 months following diagnosis. HRQoL-scores, measured with the EORTC QLQ-H&N35 inventory, self-reported levels of neuroticism, avoidance focused coping, coping by suppre...
44 CitationsSource
#1Mati NejmiH-Index: 1
#2Xin Shelley Wang (University of Texas MD Anderson Cancer Center)H-Index: 51
Last. Charles S. Cleeland (University of Texas MD Anderson Cancer Center)H-Index: 116
view all 5 authors...
Abstract Context Little is known about symptom burden–a concept encompassing both symptom severity and the degree of symptom interference with daily living–in patients with cancer in Morocco or other countries with Arabic-speaking populations. Objectives The goal of this study was to psychometrically validate the Arabic version of the M. D. Anderson Symptom Inventory (MDASI-A), a tool for measuring multiple symptoms in patients with cancer, and to test its utility in a sample of patients with la...
20 CitationsSource
#1Charles S. Cleeland (University of Texas MD Anderson Cancer Center)H-Index: 116
#2Jeff A. Sloan (Mayo Clinic)H-Index: 139
Abstract The U.S. Food and Drug Administration (FDA) 2006 draft guidance on "Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims" has engendered wide discussion about patient-reported outcome (PRO) domains that should be endpoints in clinical trials. Reducing the severity and impact of symptoms is a natural intervention endpoint for cancer, a condition associated with considerable symptom burden. Because symptoms are best described by patients who hav...
92 CitationsSource
#1Peter C. Trask (Pfizer)H-Index: 14
#2Ming-Ann HsuH-Index: 7
Last. Richard P. McQuellonH-Index: 32
view all 3 authors...
Abstract: During the past 2 decades, there have been advances in the definition, measurement, and application in clinical trials and practice of health-related quality of life (HRQOL). In addition, the importance of bringing the patient’s voice to medical decision making has been increasing. However, there remains some question as to the importance of the HRQOL construct in cancer treatment. This article addresses several issues related to HRQOL in oncology including (1) reasons for including HR...
73 CitationsSource
Cited By0
Newest